Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
(Q41789029)
scientific article published on 20 September 2008
scientific article published on 20 September 2008
Language: